GPC Biotech Inc.
Records under this name other than patents GPC Biotech Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,232,283 | Raf Inhibitors Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,450,348 | Derivatives of Squaric Acid with Anti-Proliferative Activity Formerly held In force · High confidence | In force | High confidence | |
| US 8,518,958 | Pyrido [2,3-d] Pyrimidines and Their Use as Kinase Inhibitors Formerly held Lapsed on the fee record Ended Aug 27, 2025 · High confidence | Lapsed on the fee record | Ended Aug 27, 2025 | High confidence |
| US 6,242,575 | Antibodies for detecting p27 protein Term ended Term ended Feb 21, 2017 · From the USPTO record | Term ended | Term ended Feb 21, 2017 | From the USPTO record |
| US 6,316,208 | Methods for determining isolated p27 protein levels and uses thereof Term ended Term ended Feb 3, 2017 · From the USPTO record | Term ended | Term ended Feb 3, 2017 | From the USPTO record |
| US 6,753,329 | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto Formerly held Lapsed on the fee record Ended Jun 22, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jun 22, 2016 | From the USPTO record |
| US 8,097,619 | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto Formerly held Lapsed on the fee record Ended Jan 17, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jan 17, 2016 | From the USPTO record |
| US 7,230,101 | Synthesis of methotrexate-containing heterodimeric molecules Formerly held Lapsed on the fee record Ended Jun 12, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2015 | From the USPTO record |
| US 6,635,450 | Isolated P27 protein, nucleic acid molecules encoding same, methods of identifying agents acting on same, and uses of said agents Formerly held Term ended Ended no later than May 2, 2015 · From the USPTO record | Term ended | Ended no later than May 2, 2015 | From the USPTO record |
| US 7,893,057 | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto Lapsed on the fee record Ended Feb 22, 2015 · From the USPTO record | Lapsed on the fee record | Ended Feb 22, 2015 | From the USPTO record |